Cargando…

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) rapidly turned into an unprecedented pandemic of coronavirus disease 2019 (COVID-19). This global healthcare emergency marked the third occurrence of a deadly coronavirus (CoV) into the human society after entering the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Wen, Yang, Kailin, Yang, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746807/ https://www.ncbi.nlm.nih.gov/pubmed/33344509 http://dx.doi.org/10.3389/fmolb.2020.616341

Ejemplares similares

Phytochemicals of Euphorbia hirta L. and Their Inhibitory Potential Against SARS-CoV-2 Main Protease
por: Cayona, Ruel, et al.
Publicado: (2022)

Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
por: Mahmud, Shafi, et al.
Publicado: (2021)

A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease
por: Hernández González, Jorge E., et al.
Publicado: (2022)

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M(pro)) as Potential COVID-19 Therapies
por: Piplani, Sakshi, et al.
Publicado: (2022)

Evaluation of Clove Phytochemicals as Potential Antiviral Drug Candidates Targeting SARS-CoV-2 Main Protease: Computational Docking, Molecular Dynamics Simulation, and Pharmacokinetic Profiling
por: Chandra Manivannan, Arun, et al.
Publicado: (2022)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein
por: Chourasia, Rounak, et al.
Publicado: (2020)

An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
por: Zhai, Tianhua, et al.
Publicado: (2021)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease
por: Bosken, Yuliana K., et al.
Publicado: (2020)

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease
por: Edache, Emmanuel Israel, et al.
Publicado: (2023)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
por: Xie, Yixin, et al.
Publicado: (2020)

Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
por: Abdusalam, Ashraf Ahmed Ali, et al.
Publicado: (2020)

Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2
por: Sobitan, Adebiyi, et al.
Publicado: (2021)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1–Nup98 Complex to Compete With mRNA Nuclear Export
por: Li, Tinghan, et al.
Publicado: (2022)

SARS-CoV-2 Virion Stabilization by Zn Binding
por: Morante, Silvia, et al.
Publicado: (2020)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Modeling of the thermal properties of SARS-CoV-2 S-protein
por: Niu, Ziyuan, et al.
Publicado: (2022)

Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
por: Yue, Jingwen, et al.
Publicado: (2021)

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
por: Barberis, Elettra, et al.
Publicado: (2021)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
por: Pirone, Luciano, et al.
Publicado: (2020)

Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
por: Miotto, Mattia, et al.
Publicado: (2021)

Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection
por: Huang, Jiahao, et al.
Publicado: (2022)

Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis
por: Vandelli, Andrea, et al.
Publicado: (2022)

Structural understanding of SARS-CoV-2 virus entry to host cells
por: Le, Kim, et al.
Publicado: (2023)

Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking
por: Castillo-Campos, Luis, et al.
Publicado: (2023)

Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues
por: Feng, Qiushi, et al.
Publicado: (2020)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
por: Dolskiy, Alexander A., et al.
Publicado: (2020)

Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
por: Mariano, Giuseppina, et al.
Publicado: (2020)

SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan
por: Khan, Adnan, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development
por: Malik, Yashpal S., et al.
Publicado: (2021)

CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2
por: Shademan, Behrouz, et al.
Publicado: (2022)

In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2
por: Milanetti, Edoardo, et al.
Publicado: (2021)

Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
por: Zhao, Xiaohui, et al.
Publicado: (2021)

SARS-CoV-2 infection as a potential risk factor for the development of cancer
por: Ogarek, Natalia, et al.
Publicado: (2023)

Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations
por: Yang, Rui, et al.
Publicado: (2022)

Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel
por: Cao, Yipeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l7hdnuaqjrlmfpcsc2n3096hsi